相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CYP24A1 as a Potential Target for Cancer Therapy
Toshiyuki Sakaki et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2014)
The role of melanogenesis in regulation of melanoma behavior: Melanogenesis leads to stimulation of HIF-1α expression and HIF-dependent attendant pathways
A. Slominski et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2014)
Vitamin D Metabolism, Mechanism of Action, and Clinical Applications
Daniel D. Bikle
CHEMISTRY & BIOLOGY (2014)
Increased expression of CYP24A1 correlates with advanced stages of prostate cancer and can cause resistance to vitamin D3-based therapies
Mounia Tannour-Louet et al.
FASEB JOURNAL (2014)
RORα and ROR γ are expressed in human skin and serve as receptors for endogenously produced noncalcemic 20-hydroxy- and 20,23-dihydroxyvitamin D
Andrzej T. Slominski et al.
FASEB JOURNAL (2014)
Kinetic analysis of human CYP24A1 metabolism of vitamin D via the C24-oxidation pathway
Elaine W. Tieu et al.
FEBS JOURNAL (2014)
Thematic Review Series: Fat-Soluble Vitamins: Vitamin D Cytochrome P450-mediated metabolism of vitamin D
Glenville Jones et al.
JOURNAL OF LIPID RESEARCH (2014)
The role of CYP11A1 in the production of vitamin D metabolites and their role in the regulation of epidermal functions
Andrzej T. Slominski et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2014)
Melanoma Resistance: A Bright Future for Academicians and a Challenge for Patient Advocates
Andrzej T. Slominski et al.
MAYO CLINIC PROCEEDINGS (2014)
Low 25-hydroxyvitamin D levels in people with a solid tumor cancer diagnosis: the tip of the iceberg?
Katherine Hauser et al.
SUPPORTIVE CARE IN CANCER (2014)
The role of vitamin D in reducing cancer risk and progression
David Feldman et al.
NATURE REVIEWS CANCER (2014)
Vitamin D hydroxylases CYP2R1, CYP27B1 and CYP24A1 in renal cell carcinoma
Anja Urbschat et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2013)
Expression of the vitaimin D-activating enzyme 1α-hydroxylase (CYP27B1) decreases during melanoma progression
Anna A. Brozyna et al.
HUMAN PATHOLOGY (2013)
Melanogenesis affects overall and disease-free survival in patients with stage III and IV melanoma
Anna A. Brozyna et al.
HUMAN PATHOLOGY (2013)
Serum 25-hydroxyvitamin D and breast cancer risk: a meta-analysis of prospective studies
Dan Wang et al.
TUMOR BIOLOGY (2013)
CYP24A1 inhibition facilitates the anti-tumor effect of vitamin D3 on colorectal cancer cells
Janos P. Kosa et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
The Inverse Relationship between 25-Hydroxyvitamin D and Cancer Survival: Discussion of Causation
Trude Robsahm et al.
Cancers (2013)
The Vitamin D/CYP24A1 Story in Cancer
Amanda N. King et al.
Anti-Cancer Agents in Medicinal Chemistry (2012)
25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): Its important role in the degradation of vitamin D
Glenville Jones et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2012)
Rat CYP24A1 acts on 20-hydroxyvitamin D3 producing hydroxylated products with increased biological activity
Elaine W. Tieu et al.
BIOCHEMICAL PHARMACOLOGY (2012)
25(OH)D3 in patients with ovarian cancer and its correlation with survival
M. Walentowicz-Sadlecka et al.
CLINICAL BIOCHEMISTRY (2012)
In vivo evidence for a novel pathway of vitamin D3 metabolism initiated by P450scc and modified by CYP27B1
Andrzej T. Slominski et al.
FASEB JOURNAL (2012)
Altered Expression of Key Players in Vitamin D Metabolism and Signaling in Malignant and Benign Thyroid Tumors
Isabelle Clinckspoor et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2012)
L-tyrosine and L-dihydroxyphenylalanine as hormone-like regulators of melanocyte functions
Andrzej Slominski et al.
PIGMENT CELL & MELANOMA RESEARCH (2012)
20-Hydroxyvitamin D2 is a noncalcemic analog of vitamin D with potent antiproliferative and prodifferentiation activities in normal and malignant cells
Andrzej T. Slominski et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2011)
Cytochromes P450 are essential players in the vitamin D signaling system
Inge Schuster
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2011)
High basal NF-κB activity in nonpigmented melanoma cells is associated with an enhanced sensitivity to vitamin D3 derivatives
Z. Janjetovic et al.
BRITISH JOURNAL OF CANCER (2011)
The Analysis of Receptor-binding Cancer Antigen Expressed on SiSo Cells (RCAS1) immunoreactivity within the microenvironment of the ovarian cancer lesion relative to the applied therapeutic strategy
Wojciech Jozwicki et al.
CELL AND TISSUE RESEARCH (2011)
CYP24A1 Is an Independent Prognostic Marker of Survival in Patients with Lung Adenocarcinoma
Guoan Chen et al.
CLINICAL CANCER RESEARCH (2011)
Minireview: Vitamin D: Is There a Role in Extraskeletal Health?
Sylvia Christakos et al.
ENDOCRINOLOGY (2011)
Expression of vitamin D receptor decreases during progression of pigmented skin lesions
Anna A. Brozyna et al.
HUMAN PATHOLOGY (2011)
Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions
Nair Lopes et al.
BMC CANCER (2010)
Vitamin D and the Immune System: New Perspectives on an Old Theme
Martin Hewison
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2010)
The Candidate Oncogene CYP24A1: A Potential Biomarker for Colorectal Tumorigenesis
Henrik C. Horvath et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2010)
Vitamin D, disease and therapeutic opportunities
Lori A. Plum et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
PLX4032, a selective BRAFV600E kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAFWT melanoma cells
Ruth Halaban et al.
PIGMENT CELL & MELANOMA RESEARCH (2010)
Nonclassic Actions of Vitamin D
Daniel Bikle
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
20-Hydroxycholecalciferol, Product of Vitamin D3 Hydroxylation by P450scc, Decreases NF-κB Activity by Increasing IκBα Levels in Human Keratinocytes
Zorica Janjetovic et al.
PLOS ONE (2009)
Pathways and products for the metabolism of vitamin D3 by cytochrome P450scc
Robert C. Tuckey et al.
FEBS JOURNAL (2008)
Molecular actions of vitamin D contributing to cancer prevention
James C. Fleet
MOLECULAR ASPECTS OF MEDICINE (2008)
Vitamin D deficiency
Michael F. Holick
NEW ENGLAND JOURNAL OF MEDICINE (2007)
In vitro comparison of the vitamin D endocrine system in 1,25(OH)2D3-responsive and -resistant melanoma cells
Jorg Reichrath et al.
CANCER BIOLOGY & THERAPY (2007)
Vitamin D: Its role in cancer prevention and treatment
Michael F. Holick
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY (2006)
24,25-dihydroxyvitamin D3 binds to catalase
D Larsson et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Expression of VDR and CYP24A1 mRNA in human tumors
MG Anderson et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)
Expression of vitamin D receptor and 25-hydroxyvitamin D3-1α-hydroxylase in normal and malignant human colon
D Matusiak et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
The cytochrome P450scc system opens an alternate pathway of vitamin D3 metabolism
A Slominski et al.
FEBS JOURNAL (2005)
Clinical significance of the overexpression of the candidate oncogene CYP24 in esophageal cancer
K Mimori et al.
ANNALS OF ONCOLOGY (2004)
Increased expression of 25-hydroxyvitamin D-1α-hydroxylase in dysgerminomas -: A novel form of humoral hypercalcemia of malignancy
KN Evans et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Melanin pigmentation in mammalian skin and its hormonal regulation
A Slominski et al.
PHYSIOLOGICAL REVIEWS (2004)
Prostatic 25-hydroxyvitamin D-1α-hydroxylase and its implication in prostate cancer
TC Chen et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
25-hydroxyvitamin D-1α-hydroxylase in normal and malignant colon tissue
V Tangpricha et al.
LANCET (2001)
分享论文
